-
As scientists and particularly as professors, we aim to do big things. We aim to discover new insights, create new tools, and further the scientific endeavor. And occasionally, out of our academic research may come a pro...
-
The period from 2000-2016 was one of the best of times and worst of times for tech and the Valley (dotcom, financial crisis, Google IPO, Facebook founded, unprecedented growth, and so on), and John Hennessy -- current chairman of Alphabet, also on the boards of Cisco and other organizations -- was the president of Stanford University during that entire time. Given this vantage point, what are his views on Silicon Valley (will there ever be another one, and if so where?); the "Stanford model" (for transferring IP, and talent, into the world); and of course, on education (and especially access)? Hennessy also co-founded startups, including one based on pioneering microprocessor architecture used in 99% of devices today (for which he and his collaborator won the prestigious Turing Award)... so what did it take to go from research/idea to industry/implementation? General partners Marc Andreessen and Martin Casado, who also founded startups while inside universities (Netscape, Nicira) and led them to successful exits (IPO, acquisition by VMWare), also join this episode of the a16z podcast with Sonal Chokshi to share their perspectives. But beyond those instances, how has the overall relationship and "divide" between academia and industry shifted, especially as the tech industry itself has changed... and perhaps talent has, too? Finally, in his new book, Leading Matters, Hennessy shares some of the leadership principles he's learned -- and instilling through the Knight-Hennessy Scholars Program -- offering nuanced takes on topics like humility (needs ambition), empathy (without contravening fairness and reason), and others. What does it take to build not just tech, but a successful organization?
-
As history has shown, innovation in biology is really hard. Long timelines and expensive, unexpected failures are hallmarks of the biopharmaceutical and diagnostics industry. Software has been attempting to disrupt the i...
-
Head of the largest bioengineering lab in the world, former chairman of the FDA and one of the few recipients of the National Medals of Science and of Technology and Innovation, MIT Professor Bob Langer’s work ...
-
From the significance of Google DeepMind’s AlphaGo wins to recent advances in “expert-level artificial intelligence” in playing an imperfect/ asymmetric information game like poker, toys and games have ...
-
-
-
-